If Marty Makary, M.D., is correct in saying the decline in cases dating from early January cannot be attributed to vaccines, this raises an intriguing question: Would widespread use of other treatments, such as hydroxychloroquine or ivermectin, in the early stages of the virus have saved more lives while vaccines were still under development?
“The most critical and pernicious blunder from all stakeholders involved in the pandemic response is a blind-spot on COVID-19 treatment,” said Peter A. McCullough, MD, MPH, vice chief of internal medicine and cardiovascular disease at Baylor University Medical Center. “Millions have been ill and more than 500,000 have died without task forces, panels, public presentations, and international collaboration on treatment regimens to manage patients at home in order to reduce spread, hospitalization, and death.
More HERE
